Lipid–polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives

References

• FarokhzadOLangerRNanomedicine: developing smarter therapeutic and diagnostic modalitiesAdv Drug Deliv Rev200658141456145917070960
   PubMed Web of Science ®Google Scholar
• ShiJKantoffPWWoosterRFarokhzadOCCancer nanomedicine: progress, challenges and opportunitiesNat Rev Cancer2017171203727834398
   PubMed Web of Science ®Google Scholar
• FerrariMCancer nanotechnology: opportunities and challengesNat Rev Cancer20055316117115738981
   PubMed Web of Science ®Google Scholar
• KimBYRutkaJTChanWCNanomedicineN Engl J Med2010363252434244321158659
   PubMed Web of Science ®Google Scholar
• KamalyNXiaoZValenciaPMRadovic-MorenoAFFarokhzadOCTargeted polymeric therapeutic nanoparticles: design, development and clinical translationChem Soc Rev20124172971301022388185
   PubMed Web of Science ®Google Scholar
• KamalyNYameenBWuJFarokhzadOCDegradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug releaseChem Rev201611642602266326854975
   PubMed Web of Science ®Google Scholar
• ZhengYWangLLuLWangQBenicewiczBCpH and thermal dual-responsive nanoparticles for controlled drug delivery with high loading contentACS Omega2017273399340530023694
   PubMed Web of Science ®Google Scholar
• AlbaneseATangPSChanWCThe effect of nanoparticle size, shape, and surface chemistry on biological systemsAnnu Rev Biomed Eng201214111622524388
   PubMedGoogle Scholar
• ChoEJHolbackHLiuKCAbouelmagdSAParkJYeoYNanoparticle characterization: state of the art, challenges, and emerging technologiesMol Pharm20131062093211023461379
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• BurgessPHuttPBFarokhzadOCLangerRMinickSZaleSOn firm ground: IP protection of therapeutic nanoparticlesNat Biotechnol201028121267127021139609
   PubMed Web of Science ®Google Scholar
• FarokhzadOCLangerRImpact of nanotechnology on drug deliveryACS Nano200931162019206243
   PubMed Web of Science ®Google Scholar
• ZhangLGuFXChanJMWangAZLangerRSFarokhzadOCNanoparticles in medicine: therapeutic applications and developmentsClin Pharmacol Ther200883576176917957183
   PubMed Web of Science ®Google Scholar
• WagnerVDullaartABockAKZweckAThe emerging nanomedicine landscapeNat Biotechnol200624101211121717033654
   PubMed Web of Science ®Google Scholar
• BulbakeUDoppalapudiSKommineniNKhanWLiposomal formulations in clinical use: an updated reviewPharmaceutics20179412
   PubMed Web of Science ®Google Scholar
• GradisharWJTjulandinSDavidsonNPhase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancerJ Clin Oncol200523317794780316172456
   PubMed Web of Science ®Google Scholar
• Maier-HauffKUlrichFNestlerDEfficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJ Neurooncol2011103231732420845061
   PubMed Web of Science ®Google Scholar
• MoghimiSMSzebeniJStealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding propertiesProg Lipid Res200342646347814559067
   PubMed Web of Science ®Google Scholar
• TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov20054214516015688077
   PubMed Web of Science ®Google Scholar
• BarenholzYDoxil(R)-the first FDA-approved nanodrug: lessons learnedJ Control Release2012160211713422484195
   PubMed Web of Science ®Google Scholar
• PetersenGHAlzghariSKCheeWSankariSSLa-BeckNMMeta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicinJ Control Release201623225526427108612
   PubMed Web of Science ®Google Scholar
• ChenECFathiATBrunnerAMReformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AMLOnco Targets Ther2018113425343429928134
   PubMed Web of Science ®Google Scholar
• FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A2006103166315632016606824
   PubMed Web of Science ®Google Scholar
• TorchilinVPMicellar nanocarriers: pharmaceutical perspectivesPharm Res200624111617109211
   PubMed Web of Science ®Google Scholar
• KimTYKimDWChungJYPhase I and pharmacokinetic study of genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignanciesClin Cancer Res200410113708371615173077
   PubMed Web of Science ®Google Scholar
• AhnHKJungMSymSJA phase II trial of cremorphor EL-free paclitaxel (genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancerCancer Chemother Pharmacol201474227728224906423
   PubMedGoogle Scholar
• ZhangLChanJMGuFXSelf-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platformACS Nano2008281696170219206374
   PubMed Web of Science ®Google Scholar
• WakaskarRRGeneral overview of lipid–polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomesJ Drug Target201826431131828797169
   PubMed Web of Science ®Google Scholar
• FangRHAryalSHuCMZhangLQuick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication methodLangmuir20102622169581696220961057
   PubMed Web of Science ®Google Scholar
• MandalBBhattacharjeeHMittalNCore–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platformNanomedicine20139447449123261500
   PubMed Web of Science ®Google Scholar
• ThevenotJTroutierALDavidLDelairTLadavièreCSteric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipidsBiomacromolecules20078113651366017958441
   PubMed Web of Science ®Google Scholar
• MieszawskaAJGianellaACormodeDPEngineering of lipid-coated PLGA nanoparticles with a tunable payload of diagnostically active nanocrystals for medical imagingChem Commun (Camb)201248475835583722555311
   PubMed Web of Science ®Google Scholar
• FenartLCasanovaADehouckBEvaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrierJ Pharmacol Exp Ther199929131017102210565819
   PubMed Web of Science ®Google Scholar
• WangHZhaoPSuWPLGA/polymeric liposome for targeted drug and gene co-deliveryBiomaterials201031338741874820727587
   PubMed Web of Science ®Google Scholar
• TroutierALDelairTPichotCLadavièreCPhysicochemical and interfacial investigation of lipid/polymer particle assembliesLangmuir20052141305131315697275
   PubMed Web of Science ®Google Scholar
• MesserschmidtSKMusyanovychAAltvaterMTargeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cellsJ Control Release20091371697719306900
   PubMedGoogle Scholar
• SenguptaSEavaroneDCapilaITemporal targeting of tumour cells and neovasculature with a nanoscale delivery systemNature2005436705056857216049491
   PubMed Web of Science ®Google Scholar
• HuCMZhangLAryalSCheungCFangRHZhangLErythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProc Natl Acad Sci U S A201110827109801098521690347
   PubMed Web of Science ®Google Scholar
• De MiguelIImbertieLRieumajouVMajorMKravtzoffRBetbederDProofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriersPharm Res200017781782410990200
   PubMed Web of Science ®Google Scholar
• HitzmanCJElmquistWFWattenbergLWWiedmannTSDevelopment of a respirable, sustained release microcarrier for 5-fluorouracil I: In vitro assessment of liposomes, microspheres, and lipid coated nanoparticlesJ Pharm Sci20069551114112616570302
   PubMed Web of Science ®Google Scholar
• LiXAntonNArpagausCBelleteixFVandammeTFNanoparticles by spray drying using innovative new technology: the Büchi nano spray dryer B-90J Control Release2010147230431020659510
   PubMed Web of Science ®Google Scholar
• HasanWChuKGullapalliADelivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancerNano Lett201212128729222165988
   PubMed Web of Science ®Google Scholar
• BarichelloJMMorishitaMTakayamaKNagaiTEncapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation methodDrug Dev Ind Pharm199925447147610194602
   PubMed Web of Science ®Google Scholar
• SuXFrickeJKavanaghDGIrvineDJIn vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticlesMol Pharm20118377478721417235
   PubMed Web of Science ®Google Scholar
• ValenciaPMBastoPAZhangLSingle-step assembly of homogenous lipid-polymeric and lipid-quantum dot nanoparticles enabled by microfluidic rapid mixingACS Nano2010431671167920166699
   PubMed Web of Science ®Google Scholar
• FangRHChenKNAryalSHuCMZhangKZhangLLarge-scale synthesis of lipid-polymer hybrid nanoparticles using a multi-inlet vortex reactorLangmuir20122839138241382922950917
   PubMed Web of Science ®Google Scholar
• KimYLee ChungBMaMMass production and size control of lipid-polymer hybrid nanoparticles through controlled microvorticesNano Lett20121273587359122716029
   PubMed Web of Science ®Google Scholar
• ChanJMZhangLYuetKPPLGA–lecithin–PEG core–shell nanoparticles for controlled drug deliveryBiomaterials20093081627163419111339
   PubMed Web of Science ®Google Scholar
• YangXZDouSWangYCSingle-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNAACS Nano2012664955496522646867
   PubMed Web of Science ®Google Scholar
• ZhengYYuBWeecharangsanWTransferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7α-APTADD to breast cancer cellsInt J Pharm2010390223424120156537
   PubMed Web of Science ®Google Scholar
• MittalGSahanaDKBhardwajVRavi KumarMNEstradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivoJ Control Release20071191778517349712
   PubMed Web of Science ®Google Scholar
• ClawsonCTonLAryalSFuVEsenerSZhangLSynthesis and characterization of lipid-polymer hybrid nanoparticles with pH-triggered poly(ethylene glycol) sheddingLangmuir20112717105561056121806013
   PubMed Web of Science ®Google Scholar
• KandelPKFernandoLPAckroydPCChristensenKAIncorporating functionalized polyethylene glycol lipids into reprecipitated conjugated polymer nanoparticles for bioconjugation and targeted labeling of cellsNanoscale2011331037104521152603
   PubMedGoogle Scholar
• BershteynAChaparroJYauRPolymer-supported lipid shells, onions, and flowersSoft Matter2008491787179119756178
   PubMed Web of Science ®Google Scholar
• CheowWSHadinotoKFactors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticlesColloids Surf B Biointerfaces201185221422021439797
   PubMed Web of Science ®Google Scholar
• LiuYPanJFengSSNanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performanceInt J Pharm20103951–224325020472049
   PubMed Web of Science ®Google Scholar
• ChuCHWangYCHuangHYWuLCYangCSUltrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applicationsNanotechnology2011221818560121415469
   PubMedGoogle Scholar
• CheowWSHadinotoKLipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehiclesParticuology2012103327333
   Web of Science ®Google Scholar
• WangYKhoKCheowWSHadinotoKA comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid–polymer hybrid nanoparticlesInt J Pharm20124241–29810622226876
   PubMedGoogle Scholar
• CheowWSChangMWHadinotoKThe roles of lipid in anti-biofilm efficacy of lipid–polymer hybrid nanoparticles encapsulating antibioticsColloids Surf A Physicochem Eng Asp20113891–3158165
   Web of Science ®Google Scholar
• WangZHoPCA nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activitiesBiomaterials201031277115712320576288
   PubMed Web of Science ®Google Scholar
• ZhengMYueCMaYSingle-step assembly of DOX/ICG loaded lipid-polymer nanoparticles for highly effective chemophotothermal combination therapyACS Nano2013732056206723413798
   PubMed Web of Science ®Google Scholar
• ParkJWrzesinskiSHSternECombination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapyNat Mater2012111089590522797827
   PubMed Web of Science ®Google Scholar
• XuXXieKZhangXQEnhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrugProc Natl Acad Sci U S A201311046186381864324167294
   PubMed Web of Science ®Google Scholar
• DengZJMortonSWBen-AkivaEDreadenECShopsowitzKEHammondPTLayer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatmentACS Nano20137119571958424144228
   PubMed Web of Science ®Google Scholar
• JiangTMoRBellottiAZhouJGuZGel-liposome-mediated co-delivery of anticancer membrane-associated proteins and small-molecule drugs for enhanced therapeutic efficacyAdv Funct Mater2014241622952304
   Web of Science ®Google Scholar
• WangAZYuetKZhangLChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiationNanomedicine (Lond)20105336136820394530
   PubMed Web of Science ®Google Scholar
• AryalSHuCMZhangLPolymeric nanoparticles with precise ratio-metric control over drug loading for combination therapyMol Pharm2011841401140721696189
   PubMed Web of Science ®Google Scholar
• AryalSHuCMZhangLCombinatorial drug conjugation enables nanoparticle dual-drug deliverySmall20106131442144820564488
   PubMedGoogle Scholar
• AryalSJack HuC-MFuVZhangLNanoparticle drug delivery enhances the cytotoxicity of hydrophobic–hydrophilic drug conjugatesJ Mater Chem2012223994999
   Google Scholar
• KularatneSALowPSTargeting of nanoparticles: folate receptorMethods Mol Biol201062424926520217601
   PubMedGoogle Scholar
• WuBYuPCuiCFolate-containing reduction-sensitive lipid–polymer hybrid nanoparticles for targeted delivery of doxorubicinBiomater Sci20153465566426222425
   PubMed Web of Science ®Google Scholar
• LiuYLiKPanJLiuBFengSSFolic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of docetaxelBiomaterials201031233033819783040
   PubMed Web of Science ®Google Scholar
• WernerMEKarveSSukumarRFolate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasisBiomaterials201132338548855421843904
   PubMed Web of Science ®Google Scholar
• ZhangLZhuDDongXFolate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel deliveryInt J Nanomedicine2015102101211425844039
   PubMed Web of Science ®Google Scholar
• GuLShiTSunYFolate-modified, indocyanine green-loaded lipid-polymer hybrid nanoparticles for targeted delivery of cisplatinJ Biomater Sci Polym Ed201728769070228277002
   PubMed Web of Science ®Google Scholar
• ZhengMGongPZhengCLipid-polymer nanoparticles for folate-receptor targeting delivery of doxorubicinJ Nanosci Nanotechnol20151574792479826373039
   PubMed Web of Science ®Google Scholar
• LiYWuHYangXMitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug releaseMol Pharm20141182915292724984984
   PubMed Web of Science ®Google Scholar
• YangZLuoXZhangXLiuJJiangQTargeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid–polymer hybrid nanoparticlesBiomed Mater20138202501223507576
   PubMed Web of Science ®Google Scholar
• ZhaoYLinDWuFDiscovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug deliveryInt J Mol Sci20141510175651757625268623
   PubMed Web of Science ®Google Scholar
• GaoFZhangJFuCiRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting abilityInt J Nanomedicine2017124147416228615942
   PubMed Web of Science ®Google Scholar
• ShiKZhouJZhangQArginine-glycine-aspartic acid-modified lipid-polymer hybrid nanoparticles for docetaxel delivery in glioblastoma multiformeJ Biomed Nanotechnol201511338239126307822
   PubMedGoogle Scholar
• HuCMKaushalSTran CaoHSHalf-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cellsMol Pharm20107391492020394436
   PubMed Web of Science ®Google Scholar
• DavisMEZuckermanJEChoiCHJEvidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature201046472911067107020305636
   PubMed Web of Science ®Google Scholar
• MukherjeeABhattacharyyaJSagarMVChaudhuriALiposomally encapsulated CDC20 siRNA inhibits both solid melanoma tumor growth and spontaneous growth of intravenously injected melanoma cells on mouse lungDrug Deliv Transl Res20133322423425788131
   PubMedGoogle Scholar
• Alnylam Pharmaceuticals IncAlnylam Announces First-Ever FDA Approval of an RNAi Therapeutic, ONPATTRO™ (patisiran) for the Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults10102018 Available from: https://www.businesswire.com/news/home/20180810005398/en/Accessed February 22, 2019
   Google Scholar
• DesaiPRMarepallySPatelARVoshavarCChaudhuriASinghMTopical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivoJ Control Release20131701516323643662
   PubMed Web of Science ®Google Scholar
• ShiJXuYXuXHybrid lipid–polymer nanoparticles for sustained siRNA delivery and gene silencingNanomedicine2014105e897e900
   PubMed Web of Science ®Google Scholar
• ShiJXiaoZVotrubaARVilosCFarokhzadOCDifferentially charged hollow core/shell lipid-polymer-lipid hybrid nanoparticles for small interfering RNA deliveryAngew Chem Int Ed Engl201150317027703121698724
   PubMed Web of Science ®Google Scholar
• GaoLYLiuXYChenCJCore-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA deliveryBiomaterials20143562066207824315577
   PubMed Web of Science ®Google Scholar
• StarkBPabstGPrasslRLong-term stability of sterically stabilized liposomes by freezing and freeze-drying: effects of cryoprotectants on structureEur J Pharm Sci2010413–454655520800680
   PubMed Web of Science ®Google Scholar
• HolzerMVogelVMänteleWSchwartzDHaaseWLangerKPhysico-chemical characterisation of PLGA nanoparticles after freeze-drying and storageEur J Pharm Biopharm200972242843719462479
   PubMedGoogle Scholar
• GrigorasAGPolymer-lipid hybrid systems used as carriers for insulin deliveryNanomedicine20171382425243728821465
   PubMed Web of Science ®Google Scholar
• SilvaEJSouzaLGSilvaLADA novel polymer-lipid hybrid nanoparticle for the improvement of topotecan hydrochloride physicochemical propertiesCurr Drug Deliv201815797998629243576
   PubMedGoogle Scholar
• YaoCWuMZhangCPhotoresponsive lipid-polymer hybrid nanoparticles for controlled doxorubicin releaseNanotechnology2017282525510128561013
   PubMedGoogle Scholar
• KaczmarekJCPatelAKKauffmanKJPolymer-lipid nanoparticles for systemic delivery of mRNA to the lungsAngew Chem Int Ed Engl20165544138081381227690187
   PubMed Web of Science ®Google Scholar
• WuBLuSTDengKMRI-guided targeting delivery of doxorubicin with reduction-responsive lipid-polymer hybrid nanoparticlesInt J Nanomedicine2017126871688229066883
   PubMedGoogle Scholar
• BoboRHLaskeDWAkbasakAMorrisonPFDedrickRLOldfieldEHConvection-enhanced delivery of macromolecules in the brainProc Natl Acad Sci U S A1994916207620808134351
   PubMed Web of Science ®Google Scholar
• LiebermanDMLaskeDWMorrisonPFBankiewiczKSOldfieldEHConvection-enhanced distribution of large molecules in gray matter during interstitial drug infusionJ Neurosurg19952610211029
   Google Scholar
• CserrHFOstrachLHBulk flow of interstitial fluid after intracranial injection of blue dextran 2000Exp Neurol197445150604137563
   PubMedGoogle Scholar